• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-1 filed by Aspire Biopharma Holdings Inc.

    5/13/25 5:21:07 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ASBP alert in real time by email

    Unavailable

    Get the next $ASBP alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASBP

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ASBP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

    4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/10/25 5:25:23 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

    4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/6/25 5:00:59 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASBP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Director Fell Donald G. bought $7,800 worth of shares (20,000 units at $0.39) (SEC Form 4)

    4/A - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/10/25 5:25:23 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Fell Donald G. increased direct ownership by 5% to 20,000 units (SEC Form 4)

    4 - Aspire Biopharma Holdings, Inc. (0001847345) (Issuer)

    6/6/25 5:00:59 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASBP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

    MIAMI, April 16, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 80th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 - TodayApril 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already registered, go back to t

    4/16/25 7:00:00 AM ET
    $ASBP
    $BENF
    $BNZI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance

    Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

    MIAMI, April 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1April 16, 2025 9:00Virtual Lobby opens.Register for the Conference. If you already register

    4/15/25 7:00:00 AM ET
    $ASBP
    $BENF
    $BNZI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance

    $ASBP
    SEC Filings

    View All

    SEC Form 10-Q filed by Aspire Biopharma Holdings Inc.

    10-Q - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    8/13/25 5:02:58 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form 10-Q/A filed by Aspire Biopharma Holdings Inc.

    10-Q/A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    8/13/25 5:01:00 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aspire Biopharma Holdings Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

    7/30/25 5:29:20 PM ET
    $ASBP
    Biotechnology: Pharmaceutical Preparations
    Health Care